National Cancer Institute; Notice of Closed Meeting, 48699 [2010-19787]
Download as PDF
Federal Register / Vol. 75, No. 154 / Wednesday, August 11, 2010 / Notices
health of migrant and seasonal farmworkers
and their families and to formulate
recommendations for the Secretary of Health
and Human Services.
Agenda: The agenda includes an overview
of the Council’s general business activities.
The Council will also hear presentations
from experts on farmworker issues, including
the status of farmworker health at the local
and national levels.
The Council meeting is being held in
conjunction with the East Coast Migrant
Stream Forum sponsored by the North
Carolina Community Health Center
Association, which is being held in
Charleston, South Carolina, October 21–23,
2010.
Agenda items are subject to change as
priorities indicate.
For Further Information Contact: Marcia
Gomez, M.D., Office of Minority and Special
Populations, Bureau of Primary Health Care,
Health Resources and Services
Administration, 5600 Fishers Lane, Maryland
20857; telephone (301) 594–4897.
Dated: August 5, 2010.
Wendy Ponton,
Director, Office of Management.
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute; Notice of
Closed Meeting
sroberts on DSKD5P82C1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
I—Career Development, NCI–I Career
Development.
Date: September 21, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Sergei Radaev, PhD,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd, Rm
16:52 Aug 10, 2010
Jkt 220001
Dated: August 4, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–19787 Filed 8–10–10; 8:45 am]
[FR Doc. 2010–19783 Filed 8–10–10; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Food and Drug Administration
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the CDC announces
the following meeting of
aforementioned subcommittee:
National Institutes of Health
the meeting should contact Mark Byers,
Telephone: (770) 488–8619, E-mail:
mbyers@cdc.gov. The deadline for
notification of attendance is August 13, 2010.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: August 5, 2010.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)—National
Biosurveillance Advisory
Subcommittee (NBAS)
[FR Doc. 2010–19751 Filed 8–10–10; 8:45 am]
VerDate Mar<15>2010
8113, Bethesda, Md 20892, 301–435–5655,
sradaev@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
48699
Time and Date: 8 a.m.–3:30 p.m., August
24, 2010.
Place: Emory Conference Center Hotel,
1615 Clifton Road, N.E., Atlanta, GA 30329.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 75 people. The
public is welcome to participate during the
public comment periods. The public
comment periods are tentatively scheduled
for 10 a.m.–10:05 a.m. and 3:25 p.m.–
3:30 p.m.
Purpose: As a subcommittee to the CDC’s
ACD, the NBAS will provide counsel to the
CDC and the Federal government through the
ACD regarding a broad range of human
health surveillance issues arising from the
development and implementation of a
roadmap for the human health component of
a national biosurveillance system.
Matters to be Discussed: Agenda items will
include establishing task force action plans
for developing recommendations and
guidance in order to expand and strengthen
the national portfolio of activities in
biosurveillance practice and scientific
assessment.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Pamela Diaz, M.D., Designated Federal
Officer, ACD,CDC—NBAS, 1600 Clifton
Road, NE., M/S E–33, Atlanta, GA 30333.
Telephone: (770) 488–8806. E-mail:
pdiaz@cdc.gov. For security reasons,
members of the public interested in attending
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
[Docket No. FDA–2010–N–0004]
[FDA 225–10–0010]
Memorandum of Understanding
Between United States Food and Drug
Administration and the Centers for
Medicare and Medicaid Services
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is providing
notice of a memorandum of
understanding (MOU) between FDA and
the Centers for Medicare and Medicaid
Services (CMS), both part of the U.S.
Department of Health and Human
Services. The purpose of the MOU is to
promote collaboration and enhance
knowledge of efficiency by providing for
the sharing of information and expertise
between the Federal partners. The goals
of the collaboration are to explore ways
to further enhance information sharing
efforts through more efficient and robust
inter-agency activities; promote efficient
utilization of tools and expertise for
product analysis, validation, and risk
identification; and build infrastructure
and processes that meet the common
needs for evaluating the safety, efficacy,
utilization, coverage, payment, and
clinical benefit of drugs, biologics, and
medical devices.
DATES: The agreement became effective
June 25, 2010.
FOR FURTHER INFORMATION CONTACT:
David H. Dorsey, Office of Policy,
Planning and Budget, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 32, rm. 4222, Silver Spring,
MD 20993, 301–796–4800.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 20.108(c),
SUMMARY:
E:\FR\FM\11AUN1.SGM
11AUN1
Agencies
[Federal Register Volume 75, Number 154 (Wednesday, August 11, 2010)]
[Notices]
[Page 48699]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-19787]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Initial Review
Group, Subcommittee I--Career Development, NCI-I Career Development.
Date: September 21, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria,
VA 22314.
Contact Person: Sergei Radaev, PhD, Scientific Review Officer,
Resources and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd, Rm
8113, Bethesda, Md 20892, 301-435-5655, sradaev@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: August 5, 2010.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-19787 Filed 8-10-10; 8:45 am]
BILLING CODE 4140-01-P